Research

This week's research roundup features therapeutic anticoagulation with heparin in noncritically ill patients with COVID-19.

Topics include: Mayo Clinic Q&A podcast: How Mayo hopes to slam the door when COVID-19 comes knocking, what you need to know about COVID-19 tests, and Mayo Clinic preparing for COVID-19 vaccine boosters when approved.

This week's research roundup features the CLL international prognostic index predicts outcome in monoclonal B-cell lymphocytosis and rai 0 CLL.

This week's research roundup features a risk of late-onset breast cancer in genetically predisposed women.

Topics include: COVID vaccine urgency due to delta variant, Mayo Clinic announces new phase of vaccination requirement, Mayo Clinic Q&A podcast covers the delta variant and how to stop it, and a study shows masks offer protection as COVID infections increase.

This week's research roundup features a study on bipolar disorder cases that provide a new insight into underlying biology.

Top highlights include: Unvaccinated people at highest risk being infected by delta variant, strong immune response underlying kidney injury related to Covid, having certain type of antibodies help Covid patients avoid hospitalization, and you are you hesitant about Covid vaccine development?

This week's research roundup features a study on the prognostic role of MYC structural variants identified by NGS and FISH in multiple myeloma.

Top highlights include: Changes to outpatient visitor restrictions in Rochester, MN, Mayo Clinic Q&A podcast on the COVID-19 delta variant, and respiratory illnesses on the rise with symptoms similar to COVID-19.

This week’s research roundup features a study on acute treatments for episodic migraine in adults: A systematic review and meta-analysis.

Topic includes: new vaccine platform invented by Mayo enters COVID-19 clinical trial, Q&A on vaccination and precautions and the new work-life balancing act.

This week’s research roundup features a study on how ciliopathy protein HYLS1 coordinates the biogenesis and signaling of primary cilia by activating the ciliary lipid kinase PIPKIγ.

This week’s research roundup features a study on MAP3K7-IKK inflammatory signaling modulates AR protein degradation and prostate cancer progression.